Crocs, Inc. (NASDAQ:CROX) represented a move of 3.02 percent or $-0.53 per share and closed its previous day trading session at $13.29. 904150 Shares were traded in the last trading session with an Average Volume of 1.19 Million Shares. The stock currently has a Market Capitalization of 955.48 Million.
Crocs, Inc. is a world leader in innovative casual footwear for men, women and children. Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. All Crocs? shoes feature Croslite? material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, lightweight, non-marking and odor-resistant qualities that Crocs fans have known and love. Crocs celebrates the fun of being a little different and encourages fans to Find Your Fun in every colorful pair of shoes.
The stock traded between $ 5.93 and $14.47 over 1-Year time period showing its price to sales ratio of 0.94. Crocs, Inc. (NASDAQ:CROX) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $3.97 and 200-Day Simple Moving Average of $38.59. Its Price to Free Cash Flow is 43.83 and Price to Book of 4.08.
Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Crocs, Inc. (NASDAQ:CROX) reported its Actual EPS of $-0.03/share. The analysts offering Earnings Estimates for the company were believing that Crocs, Inc. could bring EPS of $-0.05/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 40 Percent.
Achaogen, Inc. (NASDAQ:AKAO)
In the last trading session, Achaogen, Inc. (NASDAQ:AKAO) added its value by -0.64% closing at the price of $10.91. The stock currently has market capitalization of 466.95 Million, with average volume of 1.17 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Achaogen, Inc. (NASDAQ:AKAO) is showing beta of 1.11. This particular value of beta suggests that Achaogen, Inc. (NASDAQ:AKAO) has historically moved 111% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Achaogen, Inc. (NASDAQ:AKAO) is at $-3.36.
The stock currently has RSI of 48.3. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Achaogen, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR enterobacteriaceae, including carbapenem-resistant enterobacteriaceae. Achaogen, Inc. is headquartered in South San Francisco, California.
Achaogen, Inc. (NASDAQ:AKAO) topped its 52-week high price of $27.79 on 03/13/17 and 52-Week Low Price of $ 9.83 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 6.03% and monthly volatility of 5.90% respectively.